For the most up to date information on COVID-19 please visit the Department of Health website. Learn more about how the AIHW is assisting the COVID-19 response and how our other work is affected. Our Covid-19 related resources page includes a list of some existing resources which may be useful when researching issues related to COVID-19.
Australian Institute of Health and Welfare 2020. National Opioid Pharmacotherapy Statistics Annual Data collection 2019. Cat. no. PHE 266. Canberra: AIHW. Viewed 10 August 2020, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019
Australian Institute of Health and Welfare. (2020). National Opioid Pharmacotherapy Statistics Annual Data collection 2019. Retrieved from https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019
National Opioid Pharmacotherapy Statistics Annual Data collection 2019. Australian Institute of Health and Welfare, 31 March 2020, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019
Australian Institute of Health and Welfare. National Opioid Pharmacotherapy Statistics Annual Data collection 2019 [Internet]. Canberra: Australian Institute of Health and Welfare, 2020 [cited 2020 Aug. 10]. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019
Australian Institute of Health and Welfare (AIHW) 2020, National Opioid Pharmacotherapy Statistics Annual Data collection 2019, viewed 10 August 2020, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019
Get citations as an Endnote file:
PDF | 702Kb
On a snapshot day in 2019, over 50,000 clients received pharmacotherapy treatment for their opioid dependence at 2,940 dosing points across Australia. There were 3,395 authorised prescribers of opioid pharmacotherapy drugs.
On average, 15 opioid pharmacotherapy clients were treated by each prescriber
Around 1 in 10 opioid pharmacotherapy clients identified as being Aboriginal and/or Torres Strait Islander
There were 2,940 opioid pharmacotherapy dosing points
The median age of opioid pharmacotherapy clients was 43 years
Medical personnel, such as general practitioners and medical specialists, prescribe opioid pharmacotherapy. Each state and territory has a registration process through which prescribers can undergo training and become registered or authorised to prescribe opioid pharmacotherapy to clients.
Data on all registered or authorised prescribers are included in this report, except for New South Wales, Western Australia and South Australia, where prescribers are included only if they are actively prescribing to at least 1 client on the snapshot day (refer to Table T2 of the Technical notes for further details). New South Wales, Western Australia and South Australia have prescribers who prescribe in more than 1 location, and as such are counted twice. This will lead to slightly deflated client to prescriber ratios. For more details about the collection, refer to the Technical notes.
Most prescribers were authorised to prescribe more than one type of drug.
On the snapshot day in 2019, there were 3,395 authorised prescribers of opioid pharmacotherapy drugs, a 33% increase since 2015 (Table S15).
Of these prescribers, almost two-thirds (61%) were authorised to prescribe more than one type of drug. A further 22% were authorised to prescribe buprenorphine-naloxone only, and 10% were authorised to prescribe methadone only. The remaining 7.4% were located in New South Wales and Victoria, and were authorised to prescribe buprenorphine only. However, New South Wales report both buprenorphine and buprenorphine-naloxone as ‘buprenorphine only’ (Figure PRESCRIBER1).
All prescribers in Queensland, Western Australia and the Australian Capital Territory were registered to prescribe more than one type of drug in 2019 (Table S16).
Figure PRESCRIBER1alternative text Data table
Most prescribers worked in the private sector.
Prescribers are classified according to the sector in which they are working when prescribing pharmacotherapy drugs to clients.
The majority of prescribers worked in the private sector (84%) with the remainder working in the public sector (12%), correctional facilities (3%), or a combination of sectors (less than 1%) (Table 1). Victoria had the highest proportion of private prescribers (99%), followed by South Australia (87%). The Northern Territory had the highest proportion of public prescribers (83%), followed by Queensland (42%). (Table S15).
— Nil or rounded to zero.
1. The states and territories have different guidelines and policies regarding training and registration to prescribe opioid pharmacotherapy types. Refer to the Technical notes for more information.
2. The Qld total includes 33 prescribers who have a prescriber type of 'Not stated'.
Source: National opioid pharmacotherapy statistics annual data (NOPSAD) 2019 collection. Supplementary Table S15.
Of the 50,945 clients receiving pharmacotherapy treatment in Australia on a snapshot day in 2019, 65% received treatment from a private prescriber, 27% received treatment from a public prescriber, and 7% from a correctional facility prescriber (Table S12).
Private prescribers treated the majority of clients in New South Wales, Victoria, Western Australia, South Australia and Tasmania. Public prescribers treated the majority of clients in Queensland, the Australian Capital Territory and the Northern Territory (Table S3).
The ratio of clients per prescriber decreased in the last 5 years.
Between 2015 and 2019, the ratio of clients per prescriber decreased in all jurisdictions, with the exception of the ACT (from 14 clients per prescriber in 2015 to 16 clients per prescriber in 2019). In relative terms, the Northern Territory had the largest decrease (from 20 to 8 clients per prescriber). Overall, in 2019, Queensland had the highest number of clients per prescriber (27), while Victoria and the Northern Territory had the lowest (8) (Figure PRESCRIBER2).
Figure PRESCRIBER 2 alternative text Data table
Prescribers working in the public sector had, on average, almost three times as many clients as prescribers in the private sector (34 clients per prescriber compared with 12) (Table S22).
Client to prescriber ratios in both the private and public sectors remained stable between 2018 and 2019 (Table S22).
Nationally, prescribers working in correctional facilities had an average of 36 clients. This varies widely at the state and territory level, from 2 clients per prescriber in Tasmania to 76 in Victoria (Table S22). The Australian Capital Territory had the highest ratio of clients to prescribers in the public sector (59) followed by Western Australia (49). Queensland had the highest ratio of clients to prescribers in the private sector (29). Private prescribers had a lower average number of clients than public prescribers in all jurisdictions except Victoria (where there were no public prescribers) and Tasmania.
The majority (45%) of prescribers treated between 1 and 5 clients, with only 10% treating more than 50 clients. Across states and territories, the proportion of pharmacotherapy prescribers treating between 1 and 5 clients ranged from 13% in Queensland to 72% in South Australia. Around 27% of prescribers were not treating any clients on the snapshot day (Table S19).
Treatment varied between sectors.
In 2019, methadone was the most commonly prescribed drug across all sectors. However, a higher proportion of clients in correctional facilities were prescribed methadone (79% of clients) when compared with clients of private (61%) and public prescribers (56%). Clients of private prescribers were more likely to be prescribed buprenorphine-naloxone (24%) compared with public (22%) and correctional facility (7%) prescribers. Given that clients prescribed buprenorphine-naloxone in New South Wales are reported as receiving buprenorphine, the proportion of clients receiving buprenorphine-naloxone nationally is likely to be an underestimate (Table S12).
Based on 2019 unit record data from 6 states and territories (excludes data from Victoria and Queensland) on a snapshot day, clients of prescribers in correctional facilities were more likely to be:
The number of prescribers registered to prescribe more than 1 pharmacotherapy drug type increased from 1,077 in 2010 to 2,079 in 2019. Buprenorphine-naloxone only prescribers rose from 1 in 2010 to 731 in 2019. Buprenorphine only prescribers increased from 34 in 2010 to 250 in 2019, while methadone-only prescribers remained relatively stable since 2010.
The ratio of clients per prescriber varied by state and territory. Nationally, the number of clients per prescriber has dropped from 19 in 2015 to 15 in 2019. On a snapshot day in 2019, Queensland had the highest number (27) of clients per prescriber, while Victoria and the Northern Territory had the lowest (8 clients per prescriber).
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.